Suvretta Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-663,030
Closed -$116M 121
2020
Q4
$116M Sell
663,030
-126,744
-16% -$21.9M 1.66% 28
2020
Q3
$128M Buy
789,774
+326,455
+70% +$51.7M 2.3% 17
2020
Q2
$66.1M Buy
+463,319
New +$64.1M 1.42% 28
2016
Q1
Sell
-341,867
Closed -$36.3M 26
2015
Q4
$36.3M Buy
341,867
+321,730
+1,598% +$33.2M 1.79% 20
2015
Q3
$1.88M Sell
20,137
-647,068
-97% -$66.9M 0.2% 17
2015
Q2
$69.5M Buy
667,205
+390,406
+141% +$40.6M 3.29% 16
2015
Q1
$30M Buy
276,799
+8,963
+3% +$922K 1.79% 22
2014
Q4
$24.8M Buy
+267,836
New +$23.7M 1.77% 22

Other funds holding LH

Suvretta Capital Management's LH Position: Q1 2021 in Review

Suvretta Capital Management sold out of Labcorp (LH) in Q1 2021, closing a stake of 663,030 shares — an estimated $116M sold.

Suvretta Capital Management first reported a position in LH in Q4 2014 and held it in 8 quarters. The position peaked at $128M in Q3 2020. 920 funds tracked by Wall St. Rank hold LH as of Q1 2021.

  • Suvretta Capital Management reported no remaining Labcorp position as of Q1 2021 after selling out during the quarter.
  • Suvretta Capital Management sold 663,030 Labcorp shares in Q1 2021, an estimated $116M.
  • Suvretta Capital Management first reported a position in Labcorp in Q4 2014 and held it in 8 quarters.
  • Suvretta Capital Management's Labcorp position peaked at $128M in Q3 2020.
  • 920 funds tracked by Wall St. Rank held Labcorp as of Q1 2021.

Based on Suvretta Capital Management's 13F filing for Q1 2021, filed 17 May 2021.